Alligator Bioscience

LUND, Sweden, June 8, 2026 Alligator Bioscience announced a significant development in the ongoing global Phase 3 clinical trial...

Lund, Sweden – March 10, 2026 Alligator Bioscience, a clinical-stage biotechnology company focused on tumor-directed immuno-oncology therapies, has announced...

LUND, Sweden | January 9, 2026 — Alligator Bioscience announced that new clinical data from its Phase 1b/2 OPTIMIZE-1...